Enhancing models of HIV,viral hepatitis, STI’s and tuberculosis to inform and improve infectious

Dates

10/01/2014 - 09/30/2019

PI

David Dowdy, MD, PhD, ScM

The goal of this five-year project is to assist the United States Centers for Disease Control and Prevention in their approach to modeling HIV and tuberculosis.

Projects

Statins as adjunctive host-directed therapy...

This study will investigate the role of statins in combination with the first-line regimen for TB in the mouse model. In...

Read More

Modeling the impact of spatially targeted TB...

 We have developed transmission models to understand the impact of TB vaccination strategies that target hotspots of...

Read More

Modeling the impact of spatially targeted TB...

We have developed transmission models to understand the impact of TB vaccination strategies that target hotspots of...

Read More

A smoking cessation trial in HIV/AIDS...

A tobacco prevalence survey and smoking cessation trial among HIV infected patients in South Africa.

Read More

Understanding the costs and...

We have conducted an empirical costing analysis of facility-based versus community-based treatment for TB in Bangladesh and are...

Read More